-
Leptogium is a well-known lichen genus found in the tropics. Morphologically, the thallus of both species was black, but L. cochleatum thallus is approximately 90–150 µm thick, while L. moluccanum is 30–60 µm thick. The thalline of L. cochleatum is wrinkled with flat apothecial disc while L. moluccanum has smooth thalline with convex apothecial disc. The morphology of Leptogium species used in the study is presented in Fig. 1.
Figure 1.
The morpho-anatomical structures of Leptogium cochleatum (left) and Leptogium moluccanum (right).
The lichen Leptogium secondary metabolites
-
To test the presence of secondary metabolites in the lichen samples, the lichen thalli were crushed, extracted with different extracting solvents, and subjected to TLC analysis. The spray reagents used in TLC includes potassium ferricyanide-ferric chloride, Dragendorff’s reagent, Kedde reagent, Bornträger reagent, magnesium acetate in methanol, Van-Urk-Salkowski test, vanillin-sulfuric acid, and α-naphthol-sulfuric acid. The results suggest that the Leptogium species contain secondary metabolites including phenols, tannins, flavonoids, alkaloids, anthrones, triterpenes, and sterols. However, TLC analysis did not detect cardenolides, antraquinones, coumarins, indoles, and sugars in both L. cochleatum and L. moluccanum. It is also worth noting that similar results were obtained using polar solvents DCM and methanol, as opposed to hexane, a non-polar solvent (Table 1).
Table 1. Thin-layer chromatography analysis of L. cochleatum and L. moluccanum in solvent system.
Spray
reagentPositive
resultL. cochleatum L. moluccanum Compounds present Hexane DCM Methanol Hexane DCM Methanol A Blue + + + + + + Phenols, tannins, flavonoids B Brown-orange − + + + + + Alkaloids C Blur to red-violet − − − − − − Cardenolides D Orange, Yellow, Blue − − − − − +(2) Antraquinones (1), anthrones (2), coumarines (3) E Orange-violet − − − − − − Anthraquinones F Blue violet − − − − − − Indoles G Blue violet + + + + − − Triterpenes, sterols H Blue − − − − − − Sugars The spray reagents used include A, potassium ferricyanide-ferric chloride; B, Dragendorff’s reagent; C, Kedde reagent; D, Bornträger reagent; E, magnesium acetate in methanol; F, Van-Urk-Salkowski test; G, vanillin-sulfuric acid; and H, α-Naphthol-sulfuric acid. Antibacterial assay
-
For the antibacterial activity assay of the lichen extracts of L. cochleatum and L. moluccanum, hexane extract of L. moluccanum showed the highest ZOI of 17.14 mm against K. pneumoniae, although the methanol extract of L. cochleatum showed activity. Both hexane and dichloromethane extract of L. cochleatum showed the highest ZOI against E. agglomerans, while the dichloromethane extract of L. cochleatum showed a ZOI of 14.84 mm against E. coli. The mean ZOI of the lichen extracts against each bacterium are shown in Table 2. Overall, four extracts showed activity against three bacterial pathogens. Hexane extract of L. moluccanum against K. pneumoniae, hexane and DCM extracts of L. cochleatum against E. agglomerans, and DCM extract of L. cochleatum against E. coli have very active inhibitory potential against the said organisms. Based on the ZOI standards by Guevarra[21], five samples that showed activity against the pathogenic bacteria. One extract exhibited partial activity against K. pneumoniae, while the other showed higher activity against K. pneumoniae (1), E. coli (1) and E. agglomerans (2) (Fig. 2).
Table 2. Mean of the ZOI (mm) of the Leptogium extracts against the test pathogenic bacteria.
CP TC L. cochleatum L. moluccanum Haxane DCM Methanol Hexane DCM Methanol K. pneumoniae 32.06 24.46 7.96 8.94 10 17.14 7.72 6.89 S. aureus 35.7 30.6 7.68 6.79 8.83 8.18 6.34 6 P. aeruginosa 41.54 28.13 6.33 8.14 8.33 8 9.15 7.56 E. agglomerans 25.32 24.67 15.28 15.86 6.83 7.96 7.46 6 E. coli 25.62 20.4 6.72 14.84 6 8.81 6 6 CP, chloramphenicol; TC, tetracycline. Figure 2.
Antibacterial activity of the lichen crude extracts against the test organisms based on the zone of inhibition (ZOI) standards by Guevara[21].
Statistical analysis using one-way analysis of variance (ANOVA) showed that there is significant difference on the potential of the different lichen extracts and positive controls, tetracycline, and chloramphenicol as antibiotic agents. In the post hoc test, the mean ZOI of hexane extract of L. cochleatum showed no significant difference with the mean ZOI of both the tetracycline and chloramphenicol with p-value of 0.275721 and 0.270317, respectively. This means that the hexane extract of L. cochleatum can also inhibit the growth of E. agglomerans. This suggests that the extracts can inhibit the growth of the bacterial pathogens and the lichen compounds detected in the extracts are responsible for the antibacterial activity of lichens.
-
The authors are thankful to Mr. Mark Gabriel Galinato, and Dr. Oliver Villaflores for their expertise and guidance in the completion of this study, and to the SRL laboratory technicians for their unwavering support and understanding especially in the use of the different laboratory apparatus needed in the experimentation.
-
About this article
Cite this article
Manlapaz APB, Mariano MI, Reyes ORM, Rodriguez LC, Paguirigan JAG. 2022. Antibacterial activity of Leptogium cochleatum and Leptogium moluccanum. Studies in Fungi 7:19 doi: 10.48130/SIF-2022-0019
Antibacterial activity of Leptogium cochleatum and Leptogium moluccanum
- Received: 31 August 2022
- Accepted: 01 December 2022
- Published online: 23 December 2022
Abstract: Currently there is an increase in the emergence and re-emergence of bacterial infections, and lichens are potential sources of pharmaceutically important secondary metabolites to halt this problem. Lichens are unique plant-like organisms which are relatively less explored in the Philippines. Here, lichen extracts of Leptogium cochleatum and Leptogium moluccanum were tested against Escherichia coli, Enterobacter agglomerans, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus using paper disk diffusion assay. Hexane extract of L. moluccanum led to a 17.14 mm zone of inhibition (ZOI) against K. pneumoniae, while hexane extract of L. cochleatum led to a 15.28 mm ZOI against E. agglomerans. Dichloromethane extracts of L. cochleatum exhibited a ZOI of 15.86 mm against E. agglomerans and 14.84 mm ZOI against E. coli. The bioactivities exhibited by the lichen extracts may be due to the secondary metabolites detected using thin layer chromatography. Indeed, lichen-derived bioactive compounds hold great promise for pharmaceutical applications for the benefit of human life.